2005Acta Academiae Medicinae JiangxiRequires access

Expression of Prostate Stem Cell Antigen and Prostate Special Antigen in Prostate Adenocarcinoma Tissues and Its Significance

Gongxian Wang

Open publisher page 0 citations

Abstract

Objective To campare the expression of prostate stem cell antigen(PSCA) with that of prostate special antigen(PSA) in different prostatic tissues and the prostate adenocarcinoma tissues at different Gleason value levels.Methods Fifty-one cases of prostate adenocarcinoma,16 of prostatic intraepithelial neoplasms and 18 of benign prostatic hyperplasia were examined and analyzed by the SP immunohistochemical staining.Results There were significant differences of expressions of PSCA and PSA among prostate adenocarcinoma and prostate intraepifhelial and benign prostate hyerplasia(P0.05),however there was no difference between the expressions of the two antigens in prostate cancer tissues(P0.05).Conclusion It is possible for PSCA to become a new marker of the diagnosis of prostate adenocarcinoma in molecular pathology and a hot point of research.in the immunotheraphy of prostate adenocarcinoma.

About this research paper

What this paper is about

Objective To campare the expression of prostate stem cell antigen(PSCA) with that of prostate special antigen(PSA) in different prostatic tissues and the prostate adenocarcinoma tissues at different Gleason value levels.Methods Fifty-one cases of prostate adenocarcinoma,16 of prostatic intraepithelial neoplasms and 18 of benign prostatic hyperplasia were examined and analyzed by the SP immunohistochemical staining.Results There were significant differences of expressions of PSCA and PSA among prostate adenocarcinoma and prostate intraepifhelial and benign prostate hyerplasia(P0.05),however there was no difference between the expressions of the two antigens in prostate cancer tissues(P0.05).Conclusion It is possible for PSCA to become a new marker of the diagnosis of prostate adenocarcinoma in molecular pathology and a hot point of research.in the immunotheraphy of prostate adenocarcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To campare the expression of prostate stem cell antigen(PSCA) with that of prostate special antigen(PSA) in different prostatic tissues and the prostate adenocarcinoma tissues at different Gleason value levels.Methods Fifty-one cases of prostate adenocarcinoma,16 of prostatic intraepithelial neoplasms and 18 of benign prostatic hyperplasia were examined and analyzed by the SP immunohistochemical staining.Results There were significant differences of expressions of PSCA and PSA among prostate adenocarcinoma and prostate intraepifhelial and benign prostate hyerplasia(P0.05),however there was no difference between the expressions of the two antigens in prostate cancer tissues(P0.05).Conclusion It is possible for PSCA to become a new marker of the diagnosis of prostate adenocarcinoma in molecular pathology and a hot point of research.in the immunotheraphy of prostate adenocarcinoma.

Key concepts: Prostate, PCA3, Adenocarcinoma, Prostate cancer, Intraepithelial neoplasia, Medicine, Immunohistochemistry, Prostate-specific antigen

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of Prostate Stem Cell Antigen and Prostate Special Antigen in Prostate Adenocarcinoma Tissues and Its Significance — Research Paper | ScholarLens